Global Men's Health and Wellness Market Report 2023-2024 and 2029 Featuring L'Oreal, P&G, Nestle, Amway, Unilever, Herbalife, Vitabiotics, Koninklijke Philips, and Him & Hers Among Others
April 23, 2024 07:09 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Men's Health and Wellness Market: Analysis By Type, By Distribution Channel, By Region Size & Forecast with Impact Analysis of COVID-19 and...
Canadian Men's Health Foundation names Kenton Boston as President & CEO
April 18, 2024 08:00 ET
|
Canadian Men's Health Foundation
The Canadian Men’s Health Foundation’s board of directors is proud to announce the appointment of Kenton Boston as President & Chief Executive Officer.
Signati™ Medical Enrolls First Patient in Groundbreaking Sealed Vasectomy Procedure Trial
April 09, 2024 09:00 ET
|
Signati Medical Inc.
Providence, RI, April 09, 2024 (GLOBE NEWSWIRE) -- Signati™ Medical, a medical device company dedicated to advancing men’s health, today announced the successful enrollment of the first patient in...
Signati™ Medical, Inc. Announces Board Member Dr. Jones Joins Urology Austin
February 12, 2024 09:00 ET
|
Signati Medical Inc.
Providence, RI, Feb. 12, 2024 (GLOBE NEWSWIRE) -- LeRoy Jones, MD, Board-Certified Urologist and Signati™ Medical, Inc. Board Member, starts a new chapter in his career at Urology Austin. Dr. Jones...
Canadian Men’s Health Foundation reports that more men are addressing stress, anxiety and depression
January 18, 2024 08:00 ET
|
Canadian Men's Health Foundation
CMHF is helping more men tackle chronic stress, anxiety and depression with the MindFit Toolkit, presented by TELUS Health.
Global Erectile Dysfunction Drugs Market Research Report 2023 and 2024-2034: Regulatory Approvals Boost Market Prospects, Viagra Dominates, Research and Development Activities Surge
January 15, 2024 10:18 ET
|
Research and Markets
Dublin, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The "Global Erectile Dysfunction Drugs Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The...
Signati™ Medical, Inc. Receives FDA Approval for IDE Study
December 20, 2023 09:00 ET
|
Signati Medical Inc.
Providence, RI, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The FDA has officially approved Signati™ Medical’s Investigational Device Exemption (IDE) study! This comes on the company’s 5 year anniversary....
Signati Medical™ Receives Additional Patent Protection for its Innovative Bipolar Handpiece
September 28, 2023 09:00 ET
|
Signati Medical Inc.
Providence, RI, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Signati Medical™ is pleased to announce the issue of US patent 11,723,680 covering critical features of the bipolar handpiece used in Signati’s...
Signati™ Medical Files IDE Study with FDA
September 26, 2023 09:00 ET
|
Signati Medical Inc.
Providence, RI, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Signati™ Medical has officially filed their IDE study with the FDA. An Investigational Device Exemption (IDE) allows the investigational device to...
Marius Pharmaceuticals Expands Access of KYZATREX™ (testosterone undecanoate) to Department of Veterans Affairs (VA), Pledging Support for Proper Hormonal Balance Among Military Personnel
September 19, 2023 09:30 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, is proud to announce the...